4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid addition salt and salt crystals | Patent Number 09199995

US 09199995 B2
Application Number14177689
Publication NumberUS 20140323491 A1
Pendency1 year, 9 months, 23 days
Filled DateFeb 11, 2014
Priority DateMar 12, 2008
Publication DateOct 30, 2014
Expiration DateMar 11, 2028
Inventor/ApplicantsLawrence P. Wennogle
John Tomesch
ExaminesWILLIS, DOUGLAS M
Art Unit1624
Technology Center1600
Assignments
Intracellular Therapies Inc.
Current
Intracellular Therapies Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.